Crystal structure of (1S*,2R*)-7-benzyloxy-2-methyl-3-tosyl-2,3,4,5-tetrahydro-1H-3-benzazepin-1-ol: elucidation of the relative configuration of potent allosteric GluN2B selective NMDA receptor antagonists

被引:0
作者
Tewes, Bastian [1 ]
Frehland, Bastian [1 ]
Froehlich, Roland [2 ]
Wuensch, Bernhard [1 ,3 ]
机构
[1] Univ Munster, Inst Pharmazeut & Med Chem, Corrensstr 48, D-48149 Munster, Germany
[2] Univ Munster, Organisch Chem Inst, Corrensstr 40, D-48149 Munster, Germany
[3] Univ Munster, Cells In Mot Cluster Excellence EXC CiM 1003, D-48149 Munster, Germany
来源
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS | 2016年 / 72卷
关键词
crystal structure; NMDA receptor antagonists; GluN2B antagonists; ifenprodil analogs; tetrahydro-3-benzazepines; relative configuration; conformational restriction; hydrogen bonding;
D O I
10.1107/S2056989016005855
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
In the title compound, C25H27NO4S, which crystallized as a racemate, the relative configuration of the adjacent OH and CH3 groups on the azepine ring is trans. The seven-membered azepin ring has a chair-like conformation. The planar aromatic rings of the benzyl and tosylate moiety are inclined to the planar 3-benzazepine ring by 78.39 (15) and 77.03 (14)degrees, respectively, and to each another by 13.82 (15)degrees. In the crystal, molecules are linked via O-H center dot center dot center dot O and C-H center dot center dot center dot O hydrogen bonds, forming double-stranded chains along the a-axis direction. The chains are linked via C-H center dot center dot center dot pi interactions, forming a three-dimensional architecture.
引用
收藏
页码:683 / +
页数:10
相关论文
共 21 条
  • [1] NR2B selective NMDA antagonists:: The evolution of the ifenprodil-type pharmaeophore
    Borza, Istvan
    Domany, Gyorgy
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (07) : 687 - 695
  • [2] Ligands for glutamate receptors:: Design and therapeutic prospects
    Bräuner-Osborne, H
    Egebjerg, J
    Nielsen, EO
    Madsen, U
    Krogsgaard-Larsen, P
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) : 2609 - 2645
  • [3] Metabolism studies of ifenprodil, a potent GluN2B receptor antagonist
    Falck, Evamaria
    Begrow, Frank
    Verspohl, Eugen
    Wuensch, Bernhard
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 88 : 96 - 105
  • [4] Subunit arrangement and function in NMDA receptors
    Furukawa, H
    Singh, SK
    Mancusso, R
    Gouaux, E
    [J]. NATURE, 2005, 438 (7065) : 185 - 192
  • [5] Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors
    Karakas, Erkan
    Simorowski, Noriko
    Furukawa, Hiro
    [J]. NATURE, 2011, 475 (7355) : 249 - U170
  • [6] Ionotropic and metabotropic glutamate receptor structure and pharmacology
    Kew, JNC
    Kemp, JA
    [J]. PSYCHOPHARMACOLOGY, 2005, 179 (01) : 4 - 29
  • [7] Recent advances in the development of NR2B subtype-selective NMDA receptor antagonists
    Layton, ME
    Kelly, MJ
    Rodzinak, KJ
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (07) : 697 - 709
  • [8] Mercury CSD 2.0 -: new features for the visualization and investigation of crystal structures
    Macrae, Clare F.
    Bruno, Ian J.
    Chisholm, James A.
    Edgington, Paul R.
    McCabe, Patrick
    Pidcock, Elna
    Rodriguez-Monge, Lucia
    Taylor, Robin
    van de Streek, Jacco
    Wood, Peter A.
    [J]. JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2008, 41 : 466 - 470
  • [9] Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential
    Mony, Laetitia
    Kew, James N. C.
    Gunthorpe, Martin J.
    Paoletti, Pierre
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (08) : 1301 - 1317
  • [10] Nonius, 1998, COLLECT